MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L. has filed 17 SEC Form 4 filings (103 transaction rows) across 1 company, with disclosures dating back to 2026. 17 of those filings fall inside the rolling window. Most recent filing: May 8, 2026.
On the most recent filing, MATA NATHAN L. is listed as Chief Scientific Officer at BELITE BIO, INC. Inside the rolling window, MATA NATHAN L. reported no open-market purchases and 17 open-market sales totaling $2.7M in BLTE. The largest disclosed transaction in the window is a sale of 1,000 BLTE shares on Apr 22, 2026, worth $170K.
Companies traded
Other insiders at BLTE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.7M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| BLTE | Chief Scientific Officer | Sale | 666 | $102K | May 8 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $154K | May 7 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $156K | May 6 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $156K | May 5 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $156K | May 4 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $157K | May 1 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $156K | Apr 30 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $159K | Apr 29 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $163K | Apr 28 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $160K | Apr 27 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $166K | Apr 24 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $170K | Apr 23 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $166K | Apr 22 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $164K | Apr 21 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $160K | Apr 20 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $162K | Apr 20 | SEC ↗ | |
| BLTE | Chief Scientific Officer | Sale | 1,000 | $168K | Apr 16 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has MATA NATHAN L. made?
MATA NATHAN L. has filed 17 SEC Form 4 filings (103 transaction rows) across 1 company since 2026.
Which companies does MATA NATHAN L. trade?
MATA NATHAN L. has filed SEC Form 4 disclosures for 1 company, including BLTE.
When was MATA NATHAN L.'s most recent SEC Form 4 filing?
MATA NATHAN L.'s most recent SEC Form 4 filing on Tracefour is dated May 8, 2026.
What is MATA NATHAN L.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, MATA NATHAN L. is listed as Chief Scientific Officer.
What is MATA NATHAN L.'s total buy and sell value in the current window?
Inside the rolling retention window, MATA NATHAN L. bought $0 and sold $2.7M based on SEC Form 4 filings.
What was MATA NATHAN L.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,000 BLTE shares on 2026-04-22, worth $170K, per SEC Form 4 filings.